GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Research & Development

BioRegenx (BioRegenx) Research & Development : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is BioRegenx Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BioRegenx's Research & Development for the three months ended in Mar. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

BioRegenx Research & Development Historical Data

The historical data trend for BioRegenx's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Research & Development Chart

BioRegenx Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioRegenx Quarterly Data
Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioRegenx Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioRegenx  (OTCPK:BRGX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BioRegenx Research & Development Related Terms

Thank you for viewing the detailed overview of BioRegenx's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx (BioRegenx) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Research & Development
Comparable Companies
ZDGE STBX PODC IZEA AREN FENG HRYU MSEZ KRKR TRFE GOOGL META HKSE:00700 XAMS:PRX TSE:6098 SPOT DASH JSE:NPN BIDU HKSE:01024
Traded in Other Exchanges
N/A
Address
5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092
Website
https://www.findit.com
Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.